Studies on the local administration of 2,3,5-tri-ethylene-imino-1,4-benzoquinone (Trenimon) to epitheliomas.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D006801:Humans; D012878:Skin Neoplasms / Q000188:drug therapy*; D014228:Triaziquone / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014228:Triaziquone